NFE2L2 and sickle cell disease: Sangokoya et al. [11] demonstrated that miR-144 directly inhibits the mRNA target, nuclear factor-erythroid 2-related factor 2 (NRF2), a well-known transcription factor involved in modulating antioxidant production in sickle cell disease [11].